Suppr超能文献

Prospective Identification of Subclinical Interstitial Lung Disease in a Rheumatoid Arthritis Cohort Is Associated with the Promoter Variant.

作者信息

Matson Scott M, Deane Kevin D, Peljto Anna L, Bang Tami J, Sachs Peter B, Walts Avram D, Collora Christopher, Ye Shuyu, Demoruelle M Kristen, Humphries Stephen M, Schwartz David A, Lee Joyce S

机构信息

University of Kansas School of Medicine Kansas City, Kansas.

University of Colorado School of Medicine Aurora, Colorado.

出版信息

Am J Respir Crit Care Med. 2022 Feb 15;205(4):473-476. doi: 10.1164/rccm.202109-2087LE.

Abstract
摘要

相似文献

2
MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.
N Engl J Med. 2018 Dec 6;379(23):2209-2219. doi: 10.1056/NEJMoa1801562. Epub 2018 Oct 20.
3
Lifetime risk of rheumatoid arthritis-associated interstitial lung disease in mutation carriers.
Ann Rheum Dis. 2021 Dec;80(12):1530-1536. doi: 10.1136/annrheumdis-2021-220698. Epub 2021 Aug 3.
4
Towards clinical significance of the promoter variant and risk of rheumatoid arthritis-associated interstitial lung disease.
Ann Rheum Dis. 2021 Dec;80(12):1503-1504. doi: 10.1136/annrheumdis-2021-220856. Epub 2021 Aug 3.
6
Associations of the MUC5B promoter variant with timing of interstitial lung disease and rheumatoid arthritis onset.
Rheumatology (Oxford). 2022 Nov 28;61(12):4915-4923. doi: 10.1093/rheumatology/keac152.
7
A Risk Score to Detect Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease.
Arthritis Rheumatol. 2022 Nov;74(11):1755-1765. doi: 10.1002/art.42162. Epub 2022 Oct 5.
8
MUC5B promoter variant rs35705950 and rheumatoid arthritis associated interstitial lung disease survival and progression.
Semin Arthritis Rheum. 2021 Oct;51(5):996-1004. doi: 10.1016/j.semarthrit.2021.07.002. Epub 2021 Jul 10.
9
Integrating Genomics Into Management of Fibrotic Interstitial Lung Disease.
Chest. 2019 May;155(5):1026-1040. doi: 10.1016/j.chest.2018.12.011. Epub 2019 Jan 17.
10
A common MUC5B promoter polymorphism and pulmonary fibrosis.
N Engl J Med. 2011 Apr 21;364(16):1503-12. doi: 10.1056/NEJMoa1013660.

引用本文的文献

1
Blurred Boundaries: Rethinking Disease Classifications in Interstitial Lung Disease Using Molecular Signals.
Am J Respir Crit Care Med. 2025 Aug;211(8):1333-1334. doi: 10.1164/rccm.202503-0720ED.
3
Peripheral Biomarker Signatures in Rheumatoid Arthritis-Associated Interstitial Lung Disease.
Arthritis Rheumatol. 2025 Aug;77(8):971-980. doi: 10.1002/art.43149. Epub 2025 Apr 7.
4
5
Biomarkers of rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis.
Front Immunol. 2024 Oct 29;15:1455346. doi: 10.3389/fimmu.2024.1455346. eCollection 2024.
6
Genomic and Serological Rheumatoid Arthritis Biomarkers, Promoter Variant, and Interstitial Lung Abnormalities.
Ann Am Thorac Soc. 2024 Oct 15;22(1):64-71. doi: 10.1513/AnnalsATS.202403-238OC.
7
Airways Abnormalities in a Prospective Cohort of Patients With Rheumatoid Arthritis.
Chest. 2025 Feb;167(2):495-506. doi: 10.1016/j.chest.2024.09.006. Epub 2024 Sep 27.
8
Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD): Update on Prevalence, Risk Factors, Pathogenesis, and Therapy.
Curr Rheumatol Rep. 2024 Dec;26(12):431-449. doi: 10.1007/s11926-024-01155-8. Epub 2024 Sep 25.
9
Impact of Sex, Serostatus, and Smoking on Risk for Rheumatoid Arthritis-Associated Interstitial Lung Disease Subtypes.
Arthritis Care Res (Hoboken). 2025 Feb;77(2):185-194. doi: 10.1002/acr.25432. Epub 2024 Oct 16.
10
Clinical Course of Interstitial Lung Disease in Patients With Rheumatoid Arthritis.
ACR Open Rheumatol. 2024 Dec;6(12):836-845. doi: 10.1002/acr2.11736. Epub 2024 Sep 7.

本文引用的文献

1
A prospective study of lung disease in a cohort of early rheumatoid arthritis patients.
Sci Rep. 2020 Sep 24;10(1):15640. doi: 10.1038/s41598-020-72768-z.
2
Baseline Characteristics and Progression of a Spectrum of Interstitial Lung Abnormalities and Disease in Rheumatoid Arthritis.
Chest. 2020 Oct;158(4):1546-1554. doi: 10.1016/j.chest.2020.04.061. Epub 2020 May 16.
3
Interstitial lung abnormalities in patients with early rheumatoid arthritis: A pilot study evaluating prevalence and progression.
Eur J Rheumatol. 2018 Oct 1;6(4):193-198. doi: 10.5152/eurjrheum.2019.19044. Print 2019 Oct.
4
MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.
N Engl J Med. 2018 Dec 6;379(23):2209-2219. doi: 10.1056/NEJMoa1801562. Epub 2018 Oct 20.
6
Idiopathic Pulmonary Fibrosis: Data-driven Textural Analysis of Extent of Fibrosis at Baseline and 15-Month Follow-up.
Radiology. 2017 Oct;285(1):270-278. doi: 10.1148/radiol.2017161177. Epub 2017 May 10.
7
Association Between Interstitial Lung Abnormalities and All-Cause Mortality.
JAMA. 2016 Feb 16;315(7):672-81. doi: 10.1001/jama.2016.0518.
8
MUC5B promoter polymorphism and interstitial lung abnormalities.
N Engl J Med. 2013 Jun 6;368(23):2192-200. doi: 10.1056/NEJMoa1216076. Epub 2013 May 21.
9
Progressive preclinical interstitial lung disease in rheumatoid arthritis.
Arch Intern Med. 2008 Jan 28;168(2):159-66. doi: 10.1001/archinternmed.2007.59.
10
Rheumatoid lung disease.
Proc Am Thorac Soc. 2007 Aug 15;4(5):443-8. doi: 10.1513/pats.200703-045MS.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验